Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous cord blood infusion for young children with autism spectrum disorder
jRCTb050240170Active, not recruiting
- Sponsor
- Stem Cell Institute
- Start
- Jul 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous umbilical cord blood in Autism Spectrum Disorder (ASD), sponsored by Stem Cell Institute. Primary endpoint: Change in Vineland II Adaptive Behavior Scale Communication Skill Domain Standard Scores. Started Jul 2025; status: active, not recruiting.
02
Drugs
autologous umbilical cord blood
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on jRCTb050240170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTb050240170.